Forcheim, Germany

Peter K Lassner


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Peter K. Lassner in Protein Compositions

Introduction

Peter K. Lassner is a notable inventor based in Forcheim, Germany. He has made significant contributions to the field of protein compositions, particularly through his innovative methods of preparing powdered protein or peptide formulations. His work has implications in various industries, including pharmaceuticals and nutrition.

Latest Patents

Peter K. Lassner holds a patent for "Powdered protein compositions and methods of making same." This patent describes a method for preparing a protein or peptide powder that involves spray drying a solution containing more than approximately 50 mg/mL of a protein or peptide, such as an antibody or antigen binding portion thereof, along with at least one excipient. The patent also details stable powdered compositions that include a protein and an excipient with less than about 6% residual moisture. This innovation is crucial for enhancing the stability and usability of protein formulations.

Career Highlights

Peter K. Lassner is associated with AbbVie Deutschland GmbH & Co. KG, where he applies his expertise in protein chemistry and formulation development. His work at AbbVie has allowed him to contribute to advancements in therapeutic protein products, which are essential for treating various medical conditions.

Collaborations

Throughout his career, Peter has collaborated with several professionals in the field, including Michael Adler and Geoffrey Lee. These collaborations have fostered a productive environment for innovation and have led to the development of new technologies in protein formulation.

Conclusion

Peter K. Lassner's contributions to the field of protein compositions exemplify the importance of innovation in scientific research and development. His patented methods and formulations continue to influence the industry, showcasing the potential of protein-based therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…